{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:44:42Z","timestamp":1792748682287,"version":"4.5.0"},"reference-count":53,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GJTC25136"],"award-info":[{"award-number":["GJTC25136"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA17104"],"award-info":[{"award-number":["CA17104"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA23156"],"award-info":[{"award-number":["CA23156"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["D.M.N. 118"],"award-info":[{"award-number":["D.M.N. 118"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018942","name":"Centro Singular de Investigaci?n de Galicia","doi-asserted-by":"publisher","award":["ED431G 2023\/03"],"award-info":[{"award-number":["ED431G 2023\/03"]}],"id":[{"id":"10.13039\/501100018942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller?a de Cultura, Educaci?n e Ordenaci?n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431B 2020\/43"],"award-info":[{"award-number":["ED431B 2020\/43"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sigma-1 (\u03c31) receptor is increasingly recognized as a \u2018pluripotent\u2019 chaperone mainly localized at the mitochondrial-associated endoplasmic reticulum membranes, where it contributes to the regulation of several pathophysiological pathways through a not fully undisclosed interactome. \u03c31 modulation with small molecules is progressively appearing promising against diverse pathologies that include neurodegenerative, oncology diseases and pain. However, only a deeper understanding of its mechanism of action may lead to \u03c31 full therapeutic exploitation and specific \u03c31 fluorescent tracers may help towards this direction. Herein, we fluorescently tagged \u03c31 reference compounds from four structurally diverse classes. The highest affinity green and red -emitting phenoxyalkylpiperidines 36 and 37 optimally probed \u03c31 receptor in flow cytometry, producing signals dose-dependently decreased by the \u03c31 reference (+)-pentazocine. The best-performing ligand 36 allowed the imaging of the \u03c31 receptor by confocal microscopy in diverse cell lines, appearing as a promising tool for advancing the understanding of \u03c31 receptor.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c02423","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:02:25Z","timestamp":1790794945000},"page":"24767-24784","source":"Crossref","is-referenced-by-count":0,"title":["From Structurally Diverse Sigma-1 (\u03c31) Receptor Reference Ligands to Live-Cell Probes: Fluorescent Phenoxyalkylpiperidines for the Detection of \u03c31 Receptor"],"prefix":"10.1021","volume":"69","author":[{"given":"Gabriella Rosanna","family":"Musillo","sequence":"first","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Serena","family":"Abatematteo","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Stiller","sequence":"additional","affiliation":[{"name":"Medical University of Vienna , , Borschkegasse 8a , ,","place":["Vienna, Austria, 1090"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Majellaro","sequence":"additional","affiliation":[{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gioe\u0301-Gallo","sequence":"additional","affiliation":[{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ortigueira","sequence":"additional","affiliation":[{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Niso","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3291-8910","authenticated-orcid":true,"given":"Anselma","family":"Liturri","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-5228","authenticated-orcid":true,"given":"Maria Grazia","family":"Perrone","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edijs","family":"Vavers","sequence":"additional","affiliation":[{"name":"University of Tartu Ravila 14a , , ,","place":["Tartu, Estonia, 50411"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-749X","authenticated-orcid":true,"given":"Ago","family":"Rinken","sequence":"additional","affiliation":[{"name":"University of Tartu Ravila 14a , , ,","place":["Tartu, Estonia, 50411"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3168-3062","authenticated-orcid":true,"given":"Winnie-Deuther","family":"Conrad","sequence":"additional","affiliation":[{"name":"Research Site Leipzig , , Permoserstra\u00dfe 15 , ,","place":["Leipzig, Germany, 04318"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Spalholz","sequence":"additional","affiliation":[{"name":"Research Site Leipzig , , Permoserstra\u00dfe 15 , ,","place":["Leipzig, Germany, 04318"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-3240","authenticated-orcid":true,"given":"Giovanni","family":"Graziano","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-3151","authenticated-orcid":true,"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Mammone","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kopecka","sequence":"additional","affiliation":[{"name":"University of Torino , , piazza Nizza 44\/bis , ,","place":["Torino, Italy, 10126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Barbaro","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-6645","authenticated-orcid":true,"given":"Emiliano","family":"Altamura","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[{"name":"University of Torino , , piazza Nizza 44\/bis , ,","place":["Torino, Italy, 10126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-8646","authenticated-orcid":true,"given":"Petra","family":"Heffeter","sequence":"additional","affiliation":[{"name":"Medical University of Vienna , , Borschkegasse 8a , ,","place":["Vienna, Austria, 1090"]},{"name":"Medical University of Vienna , Borschkegasse 8a , ,","place":["Vienna, Austria, 1090"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2812","authenticated-orcid":true,"given":"Eddy","family":"Sotelo","sequence":"additional","affiliation":[{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]},{"name":"Universidade de Santiago de Compostela , , ,","place":["Santiago de Compostela, Spain, 15782"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Colella","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-884X","authenticated-orcid":true,"given":"Carmen","family":"Abate","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro , , via E. Orabona 4 , ,","place":["Bari, Italy, 70125"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"3","key":"2026102305091144200_cit1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The Effects of Morphine- and Nalorphine- like Drugs in the Nondependent and Morphine-Dependent Chronic Spinal Dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"2026102305091144200_cit2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.tips.2019.07.006","article-title":"The Molecular Function of \u03c3 Receptors: Past, Present, and Future","volume":"40","author":"Schmidt","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"21","key":"2026102305091144200_cit3","doi-asserted-by":"publisher","first-page":"15868","DOI":"10.3390\/ijms242115868","article-title":"The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0","volume":"24","author":"Abate","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"2026102305091144200_cit4","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, Molecular Cloning, and Expression of the Mammalian Sigma1-Binding Site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7600","key":"2026102305091144200_cit5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal Structure of the Human \u03c31 Receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"issue":"10","key":"2026102305091144200_cit6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41594-018-0137-2","article-title":"Structural Basis for \u03c31 Receptor Ligand Recognition","volume":"25","author":"Schmidt","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026102305091144200_cit7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/ncomms1386","article-title":"Identification of the PGRMC1 Protein Complex as the Putative Sigma-2 Receptor Binding Site","volume":"2","author":"Xu","year":"2011","journal-title":"Nat. Commun."},{"key":"2026102305091144200_cit8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2015.03.067","article-title":"Elements in Support of the \u2018Non-Identity\u2019 of the PGRMC1 Protein with the \u03c32 Receptor","volume":"758","author":"Abate","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"2026102305091144200_cit9","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.ebiom.2015.10.017","article-title":"The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 Are Different Binding Sites Derived From Independent Genes","volume":"2","author":"Chu","year":"2015","journal-title":"EBioMedicine"},{"key":"2026102305091144200_cit10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phrs.2016.12.023","article-title":"Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 (PGRMC1) Are Two Different Proteins: Proofs by Fluorescent Labeling and Binding of Sigma-2 Receptor Ligands to PGRMC1","volume":"117","author":"Pati","year":"2017","journal-title":"Pharmacol. Res."},{"key":"2026102305091144200_cit11","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the \u03c32 receptor","author":"Alon","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7890","key":"2026102305091144200_cit12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-021-04175-x","article-title":"Structures of the \u03c32 Receptor Enable Docking for Bioactive Ligand Discovery","volume":"600","author":"Alon","year":"2021","journal-title":"Nature"},{"issue":"supplement 1","key":"2026102305091144200_cit13","first-page":"617","article-title":"Evaluation of a Simple, 18F-Labeled Radiotracer as PET Imaging Agent for Sigma-1 Receptors in the Nonhuman Primate Brain","volume":"59","author":"Jia","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"11","key":"2026102305091144200_cit14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1021\/acschemneuro.0c00171","article-title":"Positron Emission Tomography Imaging Evaluation of a Novel 18F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys","volume":"11","author":"Jia","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"2026102305091144200_cit15","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1021\/acs.jmedchem.5c03240","article-title":"Development of Second-Generation Phenoxyethylpiperidines as Potent Sigma-1 Receptor Agonists with Neuroprotective Potential for Alzheimer\u2019s Disease","volume":"69","author":"Mastropasqua","year":"2026","journal-title":"J. Med. Chem."},{"issue":"21","key":"2026102305091144200_cit16","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.3390\/molecules30214296","article-title":"A Full-Spectrum Evaluation of Sigma-1 Receptor (S1R) Positron Emission Tomography (PET) Radioligands from Binding Affinity to Clinical Imaging","volume":"30","author":"Mastropasqua","year":"2025","journal-title":"Molecules"},{"issue":"18","key":"2026102305091144200_cit17","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1021\/jm301545c","article-title":"The Sigma-2 (\u03c32) Receptor: A Novel Protein for the Imaging and Treatment of Cancer","volume":"56","author":"Mach","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026102305091144200_cit18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"24","key":"2026102305091144200_cit19","doi-asserted-by":"publisher","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","article-title":"Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases","volume":"63","author":"Ye","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026102305091144200_cit20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low Density of Sigma1 Receptors in Early Alzheimer\u2019s Disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Ann. Nucl. Med."},{"issue":"2","key":"2026102305091144200_cit21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tins.2019.12.002","article-title":"The Sigma-1 Receptor at the Crossroad of Proteostasis, Neurodegeneration, and Autophagy","volume":"43","author":"Christ","year":"2020","journal-title":"Trends Neurosci."},{"key":"2026102305091144200_cit22","unstructured":"Anavex Life Sciences Corp\n          . A Double-Blind, Randomized, Placebo-Controlled, Phase 1 Safety and Tolerability, and Pharmacokinetics Study of ANAVEX3-71; Clinical trial registration NCT04442945; clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/study\/NCT04442945 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit23","unstructured":"Anavex Life Sciences Corp\n          . A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome; Clinical trial registration NCT03941444; clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/study\/NCT03941444 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit24","unstructured":"Teva Branded Pharmaceutical Products R & D\n          , Randomized, Double-Blind, Parallel Group Study Comparing Three Doses of ACR16 Versus Placebo for the Symptomatic Treatment of Huntington Disease (HART); Clinical trial registration NCT00724048; clinicaltrials.gov; Inc. A Multi-Center, North American, 2023. https:\/\/clinicaltrials.gov\/study\/NCT00724048 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit25","unstructured":"Anavex Life Sciences Corp\n          . Open Label Extension Study for Patients With Parkinson\u2019s Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001; Clinical trial registration NCT04575259; clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/study\/NCT04575259 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit26","unstructured":"Prilenia. A Phase 2, Dose-Finding, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study, Evaluating the Safety and Efficacy of Pridopidine 45, 67.5, 90, and 112.5 Mg Twice-Daily vs Placebo for Symptomatic Treatment in Patients With Huntington\u2019s Disease; Clinical trial registration NCT02006472; clinicaltrials.gov, 2021. https:\/\/clinicaltrials.gov\/study\/NCT02006472 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit27","unstructured":"Anavex Life Sciences Corp\n          . A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of ANAVEX2-73 for Cognitive Impairment in Patients With Parkinson\u2019s Disease With Dementia; Clinical trial registration NCT03774459; clinicaltrials.gov, 2020. https:\/\/clinicaltrials.gov\/study\/NCT03774459 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit28","unstructured":"Anavex Life Sciences Corp\n          . A Phase 2b\/3, Double-Blind, Randomized, Placebo-Controlled 48-Week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer\u2019s Disease (AD); Clinical trial registration NCT03790709; clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/study\/NCT03790709 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit29","unstructured":"Prilenia\n          . A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis; Clinical trial registration NCT07322003; clinicaltrials.gov, 2026. https:\/\/clinicaltrials.gov\/study\/NCT07322003 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit30","unstructured":"Anavex Life Sciences Corp\n          . ANAVEX2-73-RS-003 Is a Phase 2\/3, Double-Blind, Randomized, Placebo-Controlled Safety and Efficacy Study in Pediatric Patients With RTT; Clinical trial registration NCT04304482; clinicaltrials.gov, 2023. https:\/\/clinicaltrials.gov\/study\/NCT04304482 (accessed July 27, 2026)."},{"key":"2026102305091144200_cit31","unstructured":"Anavex Life Sciences Corp\n          . Phase 2a Study of ANAVEX2-73 Adaptive-Trial-Design With Repeated Doses, MTD Finding, Pharmacodynamic and Bioavailability Evaluation in Patients With Mild to Moderate Alzheimer\u2019s Disease With a 12-Month Open Label Follow-Up Period; Clinical trial registration NCT02244541; clinicaltrials.gov, 2018. https:\/\/clinicaltrials.gov\/study\/NCT02244541 (accessed July 27, 2026)."},{"issue":"631","key":"2026102305091144200_cit32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3763","article-title":"Activation of the Sigma-1 Receptor Chaperone Alleviates Symptoms of Wolfram Syndrome in Preclinical Models","volume":"14","author":"Crouzier","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"6521","key":"2026102305091144200_cit33","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe9403","article-title":"Comparative Host-Coronavirus Protein Interaction Networks Reveal Pan-Viral Disease Mechanisms","volume":"370","author":"Gordon","year":"2020","journal-title":"Science"},{"key":"2026102305091144200_cit34","doi-asserted-by":"publisher","first-page":"12798","DOI":"10.1038\/s41598-023-39662-w","article-title":"Conformational Rearrangement of the SARS-CoV-2 Host Protein Sigma-1 Is Required for Antiviral Activity: Insights from a Combined in-Silico\/in-Vitro Approach","volume":"13","author":"Abatematteo","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"2026102305091144200_cit35","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1021\/acs.jcim.6c01322","article-title":"MD Simulations of Human Sigma-1 Receptor Trimer Uncover Cholesterol-Dependent Stabilization and Ligand-Specific Dynamics","volume":"66","author":"Nanna","year":"2026","journal-title":"J Chem Inf Model"},{"issue":"4","key":"2026102305091144200_cit36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/jm1013133","article-title":"Analogues of \u03c3 Receptor Ligand 1-Cyclohexyl-4-[3-(5-Methoxy-1,2,3,4-Tetrahydronaphthalen-1-Yl)Propyl]Piperazine (PB28) with Added Polar Functionality and Reduced Lipophilicity for Potential Use as Positron Emission Tomography Radiotracers","volume":"54","author":"Abate","year":"2011","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026102305091144200_cit37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/cbic.201402712","article-title":"Novel and Selective Fluorescent \u03a32-Receptor Ligand with a 3,4-Dihydroisoquinolin-1-One Scaffold: A Tool to Study \u03c32 Receptors in Living Cells","volume":"16","author":"Niso","year":"2015","journal-title":"ChemBioChem"},{"key":"2026102305091144200_cit38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmech.2015.12.014","article-title":"Development of Sigma-1 (\u03c31) Receptor Fluorescent Ligands as Versatile Tools to Study \u03c31 Receptors","volume":"108","author":"Abate","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"26","key":"2026102305091144200_cit39","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1021\/jm050654o","article-title":"Methyl Substitution on the Piperidine Ring of N -[\u03c9-(6-Methoxynaphthalen-1-Yl)Alkyl] Derivatives as a Probe for Selective Binding and Activity at the \u03c31 Receptor","volume":"48","author":"Berardi","year":"2005","journal-title":"J. Med. Chem."},{"key":"2026102305091144200_cit40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.589810","article-title":"PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti\u2212SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships","volume":"11","author":"Abate","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"2026102305091144200_cit41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1124\/jpet.107.124685","article-title":"Role of N-Methyl-D-Aspartate Receptors in Antidepressant-Like Effects of \u03c31 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-Phenylpropyl)Piperazine Dihydrochloride (SA-4503) in Olfactory Bulbectomized Rats","volume":"322","author":"Wang","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"2026102305091144200_cit42","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.3390\/ijms22126359","article-title":"Multi-Target Directed Ligands (MTDLs) Binding the \u03c31 Receptor as Promising Therapeutics: State of the Art and Perspectives","volume":"22","author":"Abatematteo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"2026102305091144200_cit43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/syn.20253","article-title":"Sigma1 and Sigma2 Receptor Binding Affinity and Selectivity of SA4503 and Fluoroethyl SA4503","volume":"59","author":"Lever","year":"2006","journal-title":"Synapse"},{"key":"2026102305091144200_cit44","doi-asserted-by":"publisher","first-page":"114038","DOI":"10.1016\/j.ejmech.2021.114038","article-title":"Development of Novel Phenoxyalkylpiperidines as High-Affinity Sigma-1 (\u03c31) Receptor Ligands with Potent Anti-Amnesic Effect","volume":"228","author":"Abatematteo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"2026102305091144200_cit45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.nucmedbio.2007.03.009","article-title":"Synthesis and Evaluation of Fluorine-18-Labeled SA4503 as a Selective Sigma1 Receptor Ligand for Positron Emission Tomography","volume":"34","author":"Kawamura","year":"2007","journal-title":"Nucl. Med. Biol."},{"issue":"8","key":"2026102305091144200_cit46","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/jm401874n","article-title":"Novel Derivatives of 1-Cyclohexyl-4-[3-(5-Methoxy-1,2,3,4-Tetrahydronaphthalen-1-Yl)Propyl]Piperazine (PB28) with Improved Fluorescent and \u03c3 Receptors Binding Properties","volume":"57","author":"Abate","year":"2014","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026102305091144200_cit47","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.bmc.2011.03.045","article-title":"Red-Fluorescent Argininamide-Type NPY Y1 Receptor Antagonists as Pharmacological Tools","volume":"19","author":"Keller","year":"2011","journal-title":"Bioorganic and Medicinal Chemistry"},{"issue":"9","key":"2026102305091144200_cit48","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.bmc.2011.03.045","article-title":"Red-Fluorescent Argininamide-Type NPY Y1 Receptor Antagonists as Pharmacological Tools","volume":"19","author":"Keller","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"2026102305091144200_cit49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jnr.21507","article-title":"Characterization and Use of the NSC\ue5f834 Cell Line for Study of Neurotrophin Receptor Trafficking","volume":"86","author":"Matusica","year":"2008","journal-title":"J of Neuroscience Research"},{"key":"2026102305091144200_cit50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ejmech.2013.09.018","article-title":"Development of 3,4-Dihydroisoquinolin-1(2H)-One Derivatives for the Positron Emission Tomography (PET) Imaging of \u03c32 Receptors","volume":"69","author":"Abate","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"2026102305091144200_cit51","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An Open-Source Platform for Biological-Image Analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"2026102305091144200_cit52","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02224-24","article-title":"The ACBD3 protein coordinates ER-Golgi contacts to enable productive TBEV infection","volume":"99","author":"Yau","year":"2025","journal-title":"J. Virol."},{"issue":"2","key":"2026102305091144200_cit53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1074\/jbc.M115.699447","article-title":"DISC1-Dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites","volume":"291","author":"Norkett","year":"2016","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c02423","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24767\/68716288\/jm6c02423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24767\/68716288\/jm6c02423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:31:08Z","timestamp":1792747868000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/24767\/5442678\/From-Structurally-Diverse-Sigma-1-1-Receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":53,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02423","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}